BromantanevsShilajit

Bromantane upregulates tyrosine hydroxylase (TH)—the rate-limiting enzyme in catecholamine synthesis—and aromatic L-amino acid decarboxylase (AADC), the enzymes responsible for converting L-tyrosine to L-DOPA and then to dopamine. This increases neuronal dopamine production capacity rather than depleting vesicular stores like traditional stimulants. The mechanism may involve modulation of transcription factors or enzyme phosphorylation. Bromantane also has anxiolytic properties through enhancement of GABAergic transmission, possibly via GABA-A receptor modulation or increased GABA synthesis. The combination of upregulated dopamine synthesis in mesolimbic and nigrostriatal pathways with GABAergic dampening of anxiety circuits produces sustained motivation, focus, and reduced mental fatigue without the jitteriness or crash typical of dopamine-releasing agents.

Fulvic acid is the primary bioactive, acting as an electron shuttle that donates and accepts electrons — enhancing mitochondrial electron transport chain efficiency by facilitating electron transfer at Complex I and II, similar to CoQ10 but through a different (non-enzymatic) mechanism. DBPs (dibenzo-alpha-pyrones) protect CoQ10 from oxidation by scavenging radicals, extending its functional life in the reduced ubiquinol form. The combination increases ATP production in mitochondria. Fulvic acid also chelates minerals (iron, zinc, magnesium) via carboxyl and phenolic groups, forming soluble complexes that transport across cell membranes via divalent metal transporter 1 (DMT1) and other channels, improving bioavailability. It has direct antioxidant effects (scavenging ROS) and anti-inflammatory effects through inhibition of complement C3 activation and NF-kB.